Martí-Climent Josep M, Prieto Elena, Elosúa César, Rodríguez-Fraile Macarena, Domínguez-Prado Inés, Vigil Carmen, García-Velloso María J, Arbizu Javier, Peñuelas Iván, Richter José A
Nuclear Medicine Department, Clínica Universidad de Navarra, 36, Pío XII Avenue, 31008 Pamplona, Spain.
Med Phys. 2014 Sep;41(9):092503. doi: 10.1118/1.4892383.
90Y-microspheres are widely used for the radioembolization of metastatic liver cancer or hepatocellular carcinoma and there is a growing interest for imaging 90Y-microspheres with PET. The aim of this study is to evaluate the performance of a current generation PET/CT scanner for 90Y imaging and to optimize the PET protocol to improve the assessment and the quantification of 90Y-microsphere biodistribution after radioembolization.
Data were acquired on a Biograph mCT-TrueV scanner with time of flight (TOF) and point spread function (PSF) modeling. Spatial resolution was measured with a 90Y point source. Sensitivity was evaluated using the NEMA 70 cm line source filled with 90Y. To evaluate the count rate performance, 90Y vials with activity ranging from 3.64 to 0.035 GBq were measured in the center of the field of view (CFOV). The energy spectrum was evaluated. Image quality with different reconstructions was studied using the Jaszczak phantom containing six hollow spheres (diameters: 31.3, 28.1, 21.8, 16.1, 13.3, and 10.5 mm), filled with a 207 kBq/ml 90Y concentration and a 5:1 sphere-to-background ratio. Acquisition time was adjusted to simulate the quality of a realistic clinical PET acquisition of a patient treated with SIR-Spheres®. The developed methodology was applied to ten patients after SIR-Spheres® treatment acquiring a 10 min per bed PET.
The energy spectrum showed the 90Y bremsstrahlung radiation. The 90Y transverse resolution, with filtered backprojection reconstruction, was 4.5 mm in the CFOV and degraded to 5.0 mm at 10 cm off-axis. 90Y absolute sensitivity was 0.40 kcps/MBq in the center of the field of view. Tendency of true and random rates as a function of the 90Y activity could be accurately described using linear and quadratic models, respectively. Phantom studies demonstrated that, due to low count statistics in 90Y PET acquisition, the optimal parameters for the standard OSEM+PSF reconstruction were only one iteration and a postreconstruction filter of 6 mm FWHM, for both TOF and non-TOF reconstructions. Moreover, when TOF is included, the signal to noise ratio increased and visibility achieved 100% by the experienced observers and 93.3% according to the Rose model of statistical detection. In 50% of patients, TOF allowed the visualization of 90Y radioembolized lesions not seen without TOF, confirming phantom results. Liver activity was accurately quantified, with no significant differences between reconstructed and actual delivered activity to the whole-liver [mean relative difference (10.2±14.7)%].
Qualitative and quantitative 90Y PET imaging improved with the introduction of TOF in a PET/CT scanner, thereby allowing the visualization of microsphere deposition in lesions not visible in non-TOF images. This technique accurately quantifies the total activity delivered to the liver during radioembolization with (90)Y-microspheres and allows dose estimation.
90Y微球广泛应用于转移性肝癌或肝细胞癌的放射性栓塞治疗,利用正电子发射断层显像(PET)对90Y微球进行成像的研究兴趣也日益浓厚。本研究旨在评估新一代PET/CT扫描仪对90Y成像的性能,并优化PET协议,以改善放射性栓塞后90Y微球生物分布的评估和定量。
在配备飞行时间(TOF)和点扩散函数(PSF)建模的Biograph mCT-TrueV扫描仪上采集数据。使用90Y点源测量空间分辨率。使用填充有90Y的NEMA 70 cm线源评估灵敏度。为评估计数率性能,在视野中心(CFOV)测量活度范围为3.64至0.035 GBq的90Y药瓶。评估能谱。使用包含六个空心球体(直径分别为31.3、28.1、21.8、16.1、13.3和10.5 mm)的Jaszczak体模研究不同重建方法的图像质量,球体填充浓度为207 kBq/ml的90Y,球体与背景比为5:1。调整采集时间以模拟接受SIR-Spheres®治疗患者的实际临床PET采集质量。将所开发的方法应用于10例接受SIR-Spheres®治疗后的患者,每位患者进行10分钟的PET扫描。
能谱显示了90Y的轫致辐射。采用滤波反投影重建时,90Y在CFOV的横向分辨率为4.5 mm,离轴10 cm处降至5.0 mm。90Y在视野中心的绝对灵敏度为0.40 kcps/MBq。真计数率和随机计数率随90Y活度变化的趋势分别可用线性模型和二次模型准确描述。体模研究表明,由于90Y PET采集中计数统计量较低,对于标准有序子集最大期望值算法(OSEM)+PSF重建,TOF和非TOF重建的最佳参数均为仅一次迭代和6 mm半高宽的重建后滤波器。此外,当包含TOF时,信噪比增加,经验丰富的观察者的可视性达到100%,根据统计检测的罗斯模型为93.3%。在50%的患者中,TOF使原本在无TOF时不可见的90Y放射性栓塞病变得以显示,证实了体模研究结果。肝脏活度得到准确量化,重建活度与实际输送至全肝的活度之间无显著差异[平均相对差异(10.2±14.7)%]。
PET/CT扫描仪中引入TOF后,90Y PET成像在定性和定量方面均得到改善,从而使微球在非TOF图像中不可见的病变中的沉积得以显示。该技术可准确量化90Y微球放射性栓塞期间输送至肝脏的总活度,并可进行剂量估计。